Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Cervical Cancer

Free Subscription 07.07.2025 1 AJPM Focus 1 AJR Am J Roentgenol 1 Aust J Gen Pract 1 Biochem Soc Trans 1 Bioinform Adv 1 Biomed Res Int 5 BMC Cancer 1 BMC Infect Dis 2 BMC Med 1 BMC Med Inform Decis Mak 1 BMC Microbiol 3 BMC Public Health 2 BMC Womens Health 1 Cancer Discov 1 Cancer Epidemiol Biomarkers Prev 1 Cell Biochem Biophys 1 Cell Commun Signal 1 Cell Signal 1 Community Health Equity Res Policy 1 Diagn Microbiol Infect Dis 2 Discov Oncol 1 Ecancermedicalscience 1 Endocr Metab Immune Disord Drug Targets 2 Eur J Surg Oncol 1 Front Cell Infect Microbiol 1 Front Neurol 2 Front Oncol 1 Front Public Health 1 Front Surg 1 Ghana Med J 1 Gynecol Oncol 1 Hum Vaccin Immunother 1 Int J Equity Health 1 J Cancer Educ 1 J Clin Transl Sci 3 J Gynecol Oncol 1 J Inflamm Res 2 J Med Virol 1 JAMA 1 JAMA Netw Open 1 Magn Reson Med Sci 1 Med Sci Monit 1 Minerva Obstet Gynecol 1 Mymensingh Med J 1 Obstet Gynecol Sci 1 Oncol Lett 1 Oncologist 1 Pathol Res Pract 1 Radiol Med 1 Reprod Sci 13 Sci Rep 1 Sichuan Da Xue Xue Bao Yi Xue Ban 1 SLAS Technol 4 Taiwan J Obstet Gynecol 1 Virchows Arch 1 Women Health 1 Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJPM Focus

1. ZANWAR PP, Shen C, Smith ML
   Cervical Cancer Screening Overuse Among Women With and Without Disability in the U.S. From 2007 to 2016.
   AJPM Focus. 2025;4:100366.
   PubMed         Abstract available
   
   

   
   AJR Am J Roentgenol

2. RAICHANDANI S
   Saying the Same Thing: Why Terminology Matters in Multidisciplinary Cervical Cancer Care.
   AJR Am J Roentgenol. 2025 Jul 2. doi: 10.2214/AJR.25.33449.
   PubMed        
   
   

   
   Aust J Gen Pract

3. CREAGH NS, Brotherton JM, Hocking JS, Karahalios A, et al
   Factors influencing healthcare practitioners' decision to offer (or not) the choice of self-collection cervical screening in general practice in Victoria, Australia.
   Aust J Gen Pract. 2025;54:477-483.
   PubMed         Abstract available
   
   

   
   Biochem Soc Trans

4. OBANYA DI, Wootton LM, Morgan EL
   Advances in understanding the mechanisms of the human papillomavirus oncoproteins.
   Biochem Soc Trans. 2025;53:565-577.
   PubMed         Abstract available
   
   

   
   Bioinform Adv

5. OMOBOYEDE V, Okonkwo NC, Balogun JO, Onyedikachi OV, et al
   Pharmacological assessment of Coffea arabica compounds as potential therapeutics for cervical cancer.
   Bioinform Adv. 2025;5:vbaf132.
   PubMed         Abstract available
   
   

   
   Biomed Res Int

6. WANG Y, Yang L, Liu Y, Ma H, et al
   Applications and Prospects of Single-Cell RNA Sequencing and Spatial Transcriptomics in Cervical Cancer.
   Biomed Res Int. 2025;2025:1532745.
   PubMed         Abstract available
   
   

   
   BMC Cancer

7. SHARMA U, Yadav BK, Rai U, Pradhan A, et al
   Concordance between MRI and clinical examination in cervical cancer staging: a retrospective study.
   BMC Cancer. 2025;25:1098.
   PubMed         Abstract available
   
   
8. SEIFU BL, Asnake AA, Belayneh T, Hailemariam T, et al
   Individual and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Kenya demographic and health surveys 2022.
   BMC Cancer. 2025;25:1067.
   PubMed         Abstract available
   
   
9. MANDIWA C, Sanna M, Gao W
   Cervical cancer screening uptake among women living with HIV in the era of universal test and treat policy in Malawi: results from the 2020-2021 Malawi population-based HIV impact assessment.
   BMC Cancer. 2025;25:1052.
   PubMed         Abstract available
   
   
10. TONGHUI B, Wufen L, Lin Q
    Single-cell sequencing reveals the role of SALL4 in cervical cancer development.
    BMC Cancer. 2025;25:1086.
    PubMed         Abstract available
    
    
11. IROWA O, Adeyeye OS, Ujah OI, Ogwuche PE, et al
    Assessment of barriers to cervical cancer screening at primary health care centers in Makurdi, North-Central Nigeria: a mixed-methods study.
    BMC Cancer. 2025;25:1099.
    PubMed         Abstract available
    
    

    
    BMC Infect Dis

12. LI Y, Wang R, Zhang J, Chen YT, et al
    A scoping review of human papillomavirus related data system in China.
    BMC Infect Dis. 2025;25:873.
    PubMed         Abstract available
    
    

    
    BMC Med

13. LIU J, Lan C, Liu T, Liu Q, et al
    Long-term efficacy and updated survival outcomes of sintilimab plus anlotinib in patients with PD-L1-positive recurrent or metastatic cervical cancer.
    BMC Med. 2025;23:369.
    PubMed         Abstract available
    
    
14. LEE A, Hawkes D, Sweeney D, Wyatt K, et al
    Exponential uptake of HPV self-collected cervical screening testing 2 years since universal availability in Victoria, Australia.
    BMC Med. 2025;23:389.
    PubMed         Abstract available
    
    

    
    BMC Med Inform Decis Mak

15. ANGYAL V, Bertalan A, Domjan P, Dinya E, et al
    Exploring the possibilities and limitations of customized large language model to support and improve cervical cancer screening.
    BMC Med Inform Decis Mak. 2025;25:242.
    PubMed         Abstract available
    
    

    
    BMC Microbiol

16. YANG Q, Dai W, Wu D, Xu R, et al
    Inferred bi-directional interactions between vaginal microbiota, metabolome and persistent HPV infection accompanied by high-grade cervical intraepithelial neoplasia.
    BMC Microbiol. 2025;25:404.
    PubMed         Abstract available
    
    

    
    BMC Public Health

17. REZAPOUR R, Saadati M, Sarsour H, Mahmoud L, et al
    Barriers and facilitators to cervical cancer screening in the Eastern Mediterranean Region: a systematic review.
    BMC Public Health. 2025;25:2370.
    PubMed         Abstract available
    
    
18. ADZIGBLI LA, Dowou RK, Gbordzoe NI, Mensah T, et al
    Cervical cancer screening uptake in Cote d'Ivoire: Analysis of prevalence and associated factors.
    BMC Public Health. 2025;25:2287.
    PubMed         Abstract available
    
    
19. DERVEEUW S, Vanthomme K, Willems S, Toma S, et al
    Migrant and ethnic inequalities in cervical cancer screening: exploring the role of cultural health capital using data from the Belgian Health Interview Survey.
    BMC Public Health. 2025;25:2262.
    PubMed         Abstract available
    
    

    
    BMC Womens Health

20. CAO M, Huang Y, Zhou Y, Wang H, et al
    Association between physical activity and gynecological cancers: a meta-analysis of prospective cohort studies.
    BMC Womens Health. 2025;25:300.
    PubMed         Abstract available
    
    
21. HILLEN C, Sachs C, Jaeger A, Prieske K, et al
    Anogenital high-risk HPV prevalence and screening considerations in female transplant recipients: a cross-sectional study.
    BMC Womens Health. 2025;25:290.
    PubMed         Abstract available
    
    

    
    Cancer Discov

22. LECOINTRE M, Guillot J, Marcone R, Ozdoganlar D, et al
    HPV16-Expressing Tumors Release Multiple IL1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Efficacy of a Therapeutic Vaccine.
    Cancer Discov. 2025;15:1458-1483.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

23. HARPER DM, Young AP, O'Dwyer MC, Olorunfemi M, et al
    Comparison of Human Papillomavirus Genotyping by Research vs. Clinical Assay for Two Self-Collection Devices.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1103-1110.
    PubMed         Abstract available
    
    

    
    Cell Biochem Biophys

24. KACI FN, Daglioglu C
    3-Aminobenzamide-linked Multifunctional Nanoparticles: A Potent Strategy for Modulating PARP1 in Cervical Cancer Cells.
    Cell Biochem Biophys. 2025 Jun 30. doi: 10.1007/s12013-025-01813.
    PubMed         Abstract available
    
    

    
    Cell Commun Signal

25. JANSARI S, Blandau A, Prokakis E, Grimm D, et al
    RNF20/RNF40 supports the aggressive behavior in cervical cancer by regulating a peroxisome-based anti-ferroptotic mechanism.
    Cell Commun Signal. 2025;23:304.
    PubMed         Abstract available
    
    

    
    Cell Signal

26. YE H, Li S, Bai J, Wan FZ, et al
    BHLHA15 promotes cervical cancer cholesterol synthesis and tumor progression.
    Cell Signal. 2025 Jun 26:111966. doi: 10.1016/j.cellsig.2025.111966.
    PubMed         Abstract available
    
    

    
    Community Health Equity Res Policy

27. NAVA M, Canizares M, Earl J, Patel H, et al
    Bridging the Gap Between Research and Policy: Exploring Political Determinants of Immigrant Health in an Urban County With High Cervical Cancer Disparities.
    Community Health Equity Res Policy. 2025 Jul 2:2752535X251352995.
    PubMed         Abstract available
    
    

    
    Diagn Microbiol Infect Dis

28. WANG M, Ma Y, Zhang N, Li L, et al
    Methylation testing versus cervical cytology for triage of HPV-positive women: A comparative study.
    Diagn Microbiol Infect Dis. 2025;113:116917.
    PubMed         Abstract available
    
    

    
    Discov Oncol

29. LI Y, Du J, Wei L, Tan T, et al
    Identification and validation of NEIL2 as a prognostic biomarker and potential therapeutic target in cervical cancer.
    Discov Oncol. 2025;16:1194.
    PubMed         Abstract available
    
    
30. MA CY, Zhao J, Xu XT, He XL, et al
    Predictive biomarkers in the gut microbiome and metabolome for severe acute radiation enteritis in cervical cancer radiotherapy.
    Discov Oncol. 2025;16:1220.
    PubMed         Abstract available
    
    

    
    Ecancermedicalscience

31. ZEUFACK SCM, Omoto J, Owaya A, Adoyo E, et al
    Feasibility of incorporating the Pocket colposcope into nurse-led cervical cancer screening programs in Western Kenya.
    Ecancermedicalscience. 2025;19:1925.
    PubMed         Abstract available
    
    

    
    Endocr Metab Immune Disord Drug Targets

32. SHARMA S, Mishra A, Pandey P
    Targeted Therapeutic Approach Employing In Silico Methods to Identify Potent Flavonoids in Cervical Cancer.
    Endocr Metab Immune Disord Drug Targets. 2025.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

33. DUAN Y, Li H, Gao Y
    Comment on "postoperative quality of life in patients with early-stage cervical cancer: A prospective 10-Year Follow-Up Study".
    Eur J Surg Oncol. 2025 Jun 23:110257. doi: 10.1016/j.ejso.2025.110257.
    PubMed        
    
    
34. MAXOVA K, Halaska MJ
    Reply to: Comment on "Postoperative quality of life in patients with early-stage cervical cancer: A prospective 10-year follow-up study".
    Eur J Surg Oncol. 2025 Jun 23:110256. doi: 10.1016/j.ejso.2025.110256.
    PubMed        
    
    

    
    Front Cell Infect Microbiol

35. CUI M, Wu Y, Liu Z, Liu Y, et al
    Advances in the interrelated nature of vaginal microecology, HPV infection, and cervical lesions.
    Front Cell Infect Microbiol. 2025;15:1608195.
    PubMed         Abstract available
    
    

    
    Front Neurol

36. HU Y, Zhong Y, Hu Y
    Altered frontotemporal glucose metabolism following radiotherapy and/or chemotherapy for cervical cancer.
    Front Neurol. 2025;16:1598913.
    PubMed         Abstract available
    
    

    
    Front Oncol

37. SUN W, Chen L, Feng X
    Epithelial cells with high TOP2A expression promote cervical cancer progression by regulating the transcription factor FOXM1.
    Front Oncol. 2025;15:1604960.
    PubMed         Abstract available
    
    
38. KOLASSERI AE, B V
    Development and validation of hybrid machine learning approach for predicting survival in patients with cervical cancer: a SEER-based population study.
    Front Oncol. 2025;15:1605378.
    PubMed         Abstract available
    
    

    
    Front Public Health

39. FEREDE KG, Ferede AG, Abdu AM, Yazew BG, et al
    Barriers and facilitators to the integration of cervical cancer screening and treatment service with antiretroviral therapy follow-up clinics for women living with HIV in Northwest Ethiopia: a qualitative study.
    Front Public Health. 2025;13:1552524.
    PubMed         Abstract available
    
    

    
    Front Surg

40. HOU W, Ma Y, Sun S, Gao Y, et al
    Predictive factors for postoperative recurrence in early cervical cancer patients: a meta-analysis.
    Front Surg. 2025;12:1588558.
    PubMed         Abstract available
    
    

    
    Ghana Med J

41. KABA G, Stevenson A, Sakyi SA, Konney TO, et al
    Analysis of Human Papillomavirus-HPV-18 and HPV-45 Type-specific variants in a contemporary cohort of individuals with cervical disease in Ghana.
    Ghana Med J. 2024;58:311-321.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

42. RANDALL L, Xiang Y, Matsumoto T, Giannarelli D, et al
    Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer.
    Gynecol Oncol. 2025;199:88-95.
    PubMed         Abstract available
    
    

    
    Hum Vaccin Immunother

43. THEOTONIO DOS SANTOS LF, Marques Fidalgo T, Cordeiro Mattos AJ, Albuquerque Ribeiro G, et al
    Education and social determinants shaping HPV vaccine uptake: Insights from a nationwide cross-sectional study.
    Hum Vaccin Immunother. 2025;21:2517488.
    PubMed         Abstract available
    
    

    
    Int J Equity Health

44. KIM SJ, Son N, Lee WR, Choi DW, et al
    Impact of fragmented care on cancer outcomes among korean women with breast and cervical cancer: a focus on regional and economic disparities.
    Int J Equity Health. 2025;24:192.
    PubMed         Abstract available
    
    

    
    J Cancer Educ

45. WANG T, Zhao Y, He H, Cai H, et al
    Analysis of Quality, Reliability, and Content of Cervical Cancer-Related Chinese Videos on TikTok.
    J Cancer Educ. 2025 Jul 1. doi: 10.1007/s13187-025-02677.
    PubMed         Abstract available
    
    

    
    J Clin Transl Sci

46. VASQUEZ GUZMAN CE, Cornejo Torres Y, Zauflik M
    A multiphase recruitment approach to enroll Latinas diagnosed with cervical cancer into a qualitative study at an academic medical center in the Pacific Northwest.
    J Clin Transl Sci. 2025;9:e127.
    PubMed         Abstract available
    
    

    
    J Gynecol Oncol

47. KIM YM, Nishio S, Kim SI, Hasegawa K, et al
    Pembrolizumab plus chemotherapy with or without bevacizumab in East Asian participants with persistent, recurrent, or metastatic cervical cancer: results from KEYNOTE-826 final analysis.
    J Gynecol Oncol. 2025;36:e110.
    PubMed         Abstract available
    
    
48. ABUDOUREXITI G, Zhang J, Abudouxikuer G
    UPF1 inhibits cervical cancer cell migration and invasion by regulating nonsense-mediated decay of BMP6 and lncRNA WAKMAR2.
    J Gynecol Oncol. 2025 Jun 23. doi: 10.3802/jgo.2025.
    PubMed         Abstract available
    
    
49. MAO Z, Long L, Yuan L, Xu Q, et al
    Risk factors associated with overall survival in patients with cervical cancer: a prospective cohort study in Western China comparing random survival forest and Cox proportional hazards models.
    J Gynecol Oncol. 2025 Jun 21. doi: 10.3802/jgo.2026.
    PubMed         Abstract available
    
    

    
    J Inflamm Res

50. LI K
    Comment on "Predictive Value of Advanced Lung Cancer Inflammation Index and Development of a Nomogram for Prognosis in Patients with Cervical Cancer Treated with Radiotherapy" [Letter].
    J Inflamm Res. 2025;18:8525-8526.
    PubMed        
    
    

    
    J Med Virol

51. CASTANEDA KM, de Waard J, Slagter-Menkema L, Mastik M, et al
    Distribution of Human Papillomavirus Genotypes in Real-World Cervical Self-Collected Scrapings From the Dutch Cervical Cancer Screening Program.
    J Med Virol. 2025;97:e70461.
    PubMed         Abstract available
    
    
52. D'AVENIA M, Dell'Anno F, Martinelli M, Santomauro L, et al
    Quality Assurance in Cervical Cancer Screening: Evaluation of Sample Adequacy in HPV DNA Testing.
    J Med Virol. 2025;97:e70482.
    PubMed         Abstract available
    
    

    
    JAMA

53. ANDERER S
    Collection Kits Boost Cervical Cancer Screening.
    JAMA. 2025 Jul 2. doi: 10.1001/jama.2025.10322.
    PubMed        
    
    

    
    JAMA Netw Open

54. BURUS T, Windon MJ, Jakubek YA, Lang Kuhs KA, et al
    Disparities in Human Papillomavirus-Associated Cancer Incidence by Appalachian Residence.
    JAMA Netw Open. 2025;8:e2518242.
    PubMed         Abstract available
    
    

    
    Magn Reson Med Sci

55. OHYA A, Fujinaga Y
    Lobular Endocervical Glandular Hyperplasia and Related Glandular Disorders: Current Status of Diagnosis with MR Imaging.
    Magn Reson Med Sci. 2025;24:332-342.
    PubMed         Abstract available
    
    

    
    Med Sci Monit

56. MICHALSKA AA, Stefaniak MM, Gotlib-Malkowska J
    Can ChatGPT Provide Patient-Friendly and Reliable Information on Cervical Cancer Screening? A Study of ChatGPT-Generated Information in Polish.
    Med Sci Monit. 2025;31:e947992.
    PubMed         Abstract available
    
    

    
    Minerva Obstet Gynecol

57. DI GIUSEPPE J, Natalini L, Marzocchini C, Lubinski I, et al
    The role of colposcopy in HPV vaccination era.
    Minerva Obstet Gynecol. 2025;77:219-236.
    PubMed         Abstract available
    
    

    
    Mymensingh Med J

58. RASHID JS, Rahman P, Khan RR, Afrin SS, et al
    High-Risk Human Papilloma Virus Genotyping in Patients with Clinically Suspected Precancerous and Cancerous Lesions of Cervix.
    Mymensingh Med J. 2025;34:816-824.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol Sci

59. ZUCHA MA, Nurputra DK, Kusumanto A, Hidayat SN, et al
    Identification of volatile organic compound (VOC) as a novel modality for cervical cancer detection.
    Obstet Gynecol Sci. 2025 Jul 1. doi: 10.5468/ogs.25038.
    PubMed         Abstract available
    
    

    
    Oncol Lett

60. WANG Y, Xia W, Shen F, Zhou J, et al
    [Retracted] tRNA-derived fragment tRF-Glu49 inhibits cell proliferation, migration and invasion in cervical cancer by targeting FGL1.
    Oncol Lett. 2025;30:404.
    PubMed         Abstract available
    
    

    
    Oncologist

61. ZHAO J, Li W, Wang Z, Liu W, et al
    Risk Assessment in a Chinese Cohort of 96,318 Females Undergoing Opportunistic Cervical Cancer Screening.
    Oncologist. 2025 Jul 1:oyaf197. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Pathol Res Pract

62. CHEN Y, Yu D, Zhu D, Muthusamy S, et al
    Exploring alkaloids and flavonoids from natural sources: Emerging natural agents for inhibiting cervical cancer progression through apoptosis induction, anti-inflammatory effects, and oxidative stress reduction.
    Pathol Res Pract. 2025;272:156092.
    PubMed         Abstract available
    
    

    
    Radiol Med

63. OU X, Liu H, Liu WV, Li Y, et al
    Assessment of magnetic resonance image compilation (MAGiC) abilities of therapeutic selection and prediction on recurrence risk factors and short-term treatment efficacy in cervical cancer.
    Radiol Med. 2025 Jul 4. doi: 10.1007/s11547-025-02042.
    PubMed         Abstract available
    
    

    
    Reprod Sci

64. ZAN Y, Liu Q, Yin Y, Guo C, et al
    Identification of hub genes and potential molecular mechanisms of tumor immune microenvironment-related radiotherapy sensitivity in locally advanced cervical cancer.
    Reprod Sci. 2025 Jun 30. doi: 10.1007/s43032-025-01909.
    PubMed         Abstract available
    
    

    
    Sci Rep

65. PANAHI-MOGHADAM S, Sadeghizadeh M, Farivar S, Vakhshiteh F, et al
    Dual functions of the DeltaNp63-miR-141-3p-YAP1 regulatory axis in cervical cancer progression are dependent on histological subtype.
    Sci Rep. 2025;15:23155.
    PubMed         Abstract available
    
    
66. JIN Y, Liu S
    Investigation of the mechanism of euphornin against cervical cancer using network pharmacology.
    Sci Rep. 2025;15:23497.
    PubMed         Abstract available
    
    
67. GOVINDARAJ P, Natarajan S, Sampath P, Suresh AT, et al
    A hybrid compound scaling hypergraph neural network for robust cervical cancer subtype classification using whole slide cytology images.
    Sci Rep. 2025;15:22201.
    PubMed         Abstract available
    
    
68. HU Q, Zuo X, Gu X, Liu L, et al
    CXCL8 is essential for cervical cancer cell acquired radioresistance and acts as a promising therapeutic target in cervical cancer.
    Sci Rep. 2025;15:20467.
    PubMed         Abstract available
    
    
69. ELSHAMI M, Khatib L, Al-Slaibi I, Alser M, et al
    Assessing the role of cervical cancer awareness in shaping attitudes toward the disease among Palestinian women.
    Sci Rep. 2025;15:21530.
    PubMed         Abstract available
    
    
70. LIU Y, Zhang Y, Zhang H, Xu D, et al
    TIGAR regulated by HPV E6 is correlated with disease stage, drug sensitivity, and immune microenvironment in cervical cancer.
    Sci Rep. 2025;15:20618.
    PubMed         Abstract available
    
    
71. JU Y, Liu X, Na J, He J, et al
    LncRNA TMPO-AS1 facilitates cervical cancer cell tumorigenesis and ferroptosis resistance via interaction with LCN2.
    Sci Rep. 2025;15:22604.
    PubMed         Abstract available
    
    
72. SU J, Lu H, Zhang R, Cui N, et al
    Cervical cancer prediction using machine learning models based on routine blood analysis.
    Sci Rep. 2025;15:22655.
    PubMed         Abstract available
    
    
73. GIL SANCHEZ LX, Bauquier C, Bujon T, Preau M, et al
    General practitioners' recommendation of HPV vaccination to adolescents aged 11-14 may be gender-biased as suggested by a qualitative study in France.
    Sci Rep. 2025;15:22642.
    PubMed         Abstract available
    
    
74. REN H, Xu R, Zhang J
    HPV transmission and optimal control of cervical cancer in China.
    Sci Rep. 2025;15:21354.
    PubMed         Abstract available
    
    
75. PU Y, Liu J, Chan KHK
    Comparative study of five-year cervical cancer cause-specific survival prediction models based on SEER data.
    Sci Rep. 2025;15:22465.
    PubMed         Abstract available
    
    
76. CHEN Y, Wang J, Heng Y, Guo Y, et al
    MIR155HG promotes metastasis and cisplatin resistance of cervical cancer cells by regulating the miR-409-3p and ZEB1 axis.
    Sci Rep. 2025;15:20541.
    PubMed         Abstract available
    
    
77. ZHANG J, Ke Y, Chen C, Jiang Z, et al
    HPV cancer burden by anatomical site, country, and region in 2022.
    Sci Rep. 2025;15:21048.
    PubMed         Abstract available
    
    

    
    Sichuan Da Xue Xue Bao Yi Xue Ban

78. WANG J, Xiao X, Yao Y
    [Advances in Multi-omics Analysis of Cervical Cancer].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2025;56:571-576.
    PubMed         Abstract available
    
    

    
    SLAS Technol

79. GOU C, Qi W, Han P, Zhang C, et al
    Effect and toxicity of PF chemotherapy combined with radiotherapy in the treatment of advanced cervical cancer : medical thermography test.
    SLAS Technol. 2025 Jul 1:100327. doi: 10.1016/j.slast.2025.100327.
    PubMed         Abstract available
    
    

    
    Taiwan J Obstet Gynecol

80. YANG ST, Wang PH, Lai CH
    Cervical cancer in Taiwan.
    Taiwan J Obstet Gynecol. 2025;64:592-595.
    PubMed        
    
    
81. WANG PH, Chao WT, Kim JW
    Is the less the better for early-stage low-risk cervical cancer?
    Taiwan J Obstet Gynecol. 2025;64:602-604.
    PubMed        
    
    
82. WANG PH, Chao WT, Kuo TC
    Locally advanced cervical cancer treatment: Immunotherapy or induction dose-dense chemotherapy?
    Taiwan J Obstet Gynecol. 2025;64:605-607.
    PubMed        
    
    
83. LIN H, Wu CH, Fu HC, Ou YC, et al
    Recent advances in cervical cancer treatment: Innovations from early-stage to advanced disease.
    Taiwan J Obstet Gynecol. 2025;64:608-615.
    PubMed         Abstract available
    
    

    
    Virchows Arch

84. MICHAL M, Kuruc J, Hajkova V, Michalova K, et al
    S100 and CD34 positive spindle cell tumors of the uterine cervix with EGFR mutation: a hitherto unrecognized neoplasm phenotypically and epigenetically overlapping with "NTRK-rearranged spindle cell neoplasms" of the uterus.
    Virchows Arch. 2025;486:1211-1219.
    PubMed         Abstract available
    
    

    
    Women Health

85. ARANOME AMF, Pereira APL, Okuyama NCM, Trugilo KP, et al
    Gene polymorphisms associated with immunosuppression and their implications in the onset of cervical cancer.
    Women Health. 2025 Jul 3:1-11. doi: 10.1080/03630242.2025.2525282.
    PubMed         Abstract available
    
    

    
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi

86. ZHOU JP, Lin YY, Zhu MF, Situ XX, et al
    [Clinical effects of extracorporeal shock wave combined with complex decongestive therapy in the treatment of lower limb lymphedema after cervical cancer surgery].
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2025;41:543-551.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.